Stay updated on PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial

Sign up to get notified when there's something new on the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    1%
    Check dated 2025-07-04T03:50:30.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    1%
    Check dated 2025-06-19T19:21:39.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:01:34.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T05:47:52.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:57:31.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The webpage has been updated to include a new study on the combination of anti-PD-1 therapy and incomplete thermal ablation for advanced hepatocellular carcinoma (HCC), with a focus on specific patient eligibility criteria and the principal investigator's name. The previous version's detailed background information on PD-1 inhibitors and their efficacy in HCC treatment has been removed.
    Difference
    28%
    Check dated 2025-04-16T02:18:38.000Z thumbnail image

Stay in the know with updates to PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page.